Brief: XSpray Pharma Gets New U.S. Patent For HyNap-Dasa
Feb 12 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* ADDITIONAL PRODUCT PATENT IN THE US FOR HYNAP-DASA
* ANNOUNCES THAT UNITED STATES PATENT AND TRADEMARK OFFICE
(USPTO)
HAS GRANTED XSPRAY A NEW US PATENT FOR HYNAP-DASA
* NEW PATENT, US 10,555,937, COVERS PHARMACEUTICAL
COMPOSITION OF
COMPANY'S PRIMARY PRODUCT CANDIDATE, HYNAP-DASA
Source text for Eikon: ID:nWkr5jLJpT
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003